- Home
- SNSE vs GSIW Comparison
SNSE vs GSIW Comparison
Compare SNSE & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- GSIW
- Stock Information
- Founded
- SNSE 2005
- GSIW 2016
- Country
- SNSE United States
- GSIW Hong Kong
- Employees
- SNSE N/A
- GSIW 17
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- SNSE Health Care
- GSIW
- Exchange
- SNSE Nasdaq
- GSIW Nasdaq
- Market Cap
- SNSE 12.3M
- GSIW 8.6M
- IPO Year
- SNSE 2021
- GSIW 2023
- Fundamental
- Price
- SNSE $0.48
- GSIW $0.56
- Analyst Decision
- SNSE Strong Buy
- GSIW
- Analyst Count
- SNSE 3
- GSIW 0
- Target Price
- SNSE $4.33
- GSIW N/A
- AVG Volume (30 Days)
- SNSE 272.7K
- GSIW 151.9K
- Earning Date
- SNSE 11-14-2024
- GSIW 12-31-2024
- Dividend Yield
- SNSE N/A
- GSIW N/A
- EPS Growth
- SNSE N/A
- GSIW N/A
- EPS
- SNSE N/A
- GSIW N/A
- Revenue
- SNSE N/A
- GSIW $1,408,469.00
- Revenue This Year
- SNSE N/A
- GSIW N/A
- Revenue Next Year
- SNSE N/A
- GSIW N/A
- P/E Ratio
- SNSE N/A
- GSIW N/A
- Revenue Growth
- SNSE N/A
- GSIW N/A
- 52 Week Low
- SNSE $0.38
- GSIW $0.52
- 52 Week High
- SNSE $1.94
- GSIW $15.99
- Technical
- Relative Strength Index (RSI)
- SNSE 45.51
- GSIW 33.82
- Support Level
- SNSE $0.42
- GSIW $0.52
- Resistance Level
- SNSE $0.50
- GSIW $0.60
- Average True Range (ATR)
- SNSE 0.04
- GSIW 0.05
- MACD
- SNSE 0.00
- GSIW 0.03
- Stochastic Oscillator
- SNSE 44.44
- GSIW 4.82
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.